NanoViricides, Inc., a publicly traded company (NYSE Amer.:NNVC) (the "Company"), and a clinical stage, leading global ...

The direct-acting antiviral glecaprevir/pibrentasvir (Mavyret) was highly effective and well tolerated in adults with acute ...

Fifty-year-old Tapestry says it provides syringe access, overdose prevention, HIV and hepatitis C testing, and health care across Western Massachusetts.

The three-dose hepatitis B vaccine has a long track record of safety, but rolling back recommendations could leave kids ...

A combination treatment involving tobevibart and elebsiran significantly improved disease activity in adults with chronic ...

WHO releases new framework to tackle drug resistance to HIV, hepatitis B and C, and STIs: Geneva Thursday, November 27, 2025, 10:00 Hrs [IST] The World Health Organization (WHO) h ...

Of the 723 people with Fibrosis-4 Index scores greater than 3.25, indicating advanced fibrosis, and 587 people with diagnosed ...

Despite untreated HBV being linked to earlier mortality, higher all-cause and liver-related death, and a 10% to 25% lifetime risk of developing hepatocellular carcinoma (HCC), only 29% of qualifying ...

The World Health Organization (WHO) has released the Integrated drug resistance action framework for HIV, hepatitis B and C and sexually transmitted infections, 2026–2030, a landmark roadmap ...

The initiative, funded by a $12 million grant from the National Institute on Drug Abuse, will evaluate how people with ...

As RFK Jr.'s new vaccine panel ponders changing the hepatitis B vaccination schedule, some doctors recall past patients, ...

Researchers from the University of Vermont and several other institutions this spring will launch a multi-year study focused ...